Posted by Michael Wonder on 22 Jul 2020
Coronavirus: pharmaceutical giants split on vaccine profits
22 July 2020 - Pharmaceutical companies are split on how they would price their potential COVID-19 vaccines, with some pledging to members of Congress that they wouldn’t seek a profit from the shots, while others indicated that they would.
During a hearing of the US House Energy and Commerce Oversight and Investigations Subcommittee, conducted by remote video, officials from companies such as AstraZeneca and Pfizer that have some of the most advanced vaccine candidates in development, expressed differences in how prices would be set for their vaccines if they are proven safe and approved for use, but they didn’t offer pricing details.
Officials from AstraZeneca and Johnson & Johnson said they would sell their vaccines at the cost of production, at least until the novel coronavirus pandemic subsides.
